VERTEX PHARMACEUTICALS INC / MA Contract with Customer, Refund Liability, Current
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Contract with Customer, Refund Liability, Current of $382.70 million as of 2019-03-31, per its 10-Q filed 2019-05-01.
Discontinued › Notes
us-gaap:ContractWithCustomerRefundLiabilityCurrent · last filed 2019-05-01
- 2019-03-31: Contract with Customer, Refund Liability, Current $382.70M.
- 2018-12-31: Contract with Customer, Refund Liability, Current $354.40M.
- 2018-09-30: Contract with Customer, Refund Liability, Current $324.25M.
- 2018-06-30: Contract with Customer, Refund Liability, Current $290.46M.
| Period end | Contract with Customer, Refund Liability, Current |
|---|---|
| 2019-03-31 | $382.70M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $354.40M 10-Q · filed 2019-05-01 |
| 2018-09-30 | $324.25M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $290.46M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $268.45M 10-Q · filed 2018-04-27 |
| 2018-01-01 | $225.13M 10-K · filed 2019-02-13 |
| 2017-12-31 | $232.40M 10-K · filed 2019-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |